SEC Form 4 · accession 0001628280-16-020509
CHAMPIONS ONCOLOGY, INC. · CSBR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joel Ackerman
Officer — Chief Executive Officer · Director
Period of report
Oct 28, 2016
Accepted (ET)
Nov 1, 2016 · 12:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000771856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Common StockF1 | $1.60 | Oct 28, 2016 | A | 279,177 | A | — | Oct 31, 2026 | Common Stock | 279,177 | 279,177 | D |
Explanation of responses
- F1The Options vest and are exercisable over a twelve month period, with vesting to occur on January 31, 2017, April 30, 2017, July 31, 2017 and October 31, 2017, respectively.